Catalyst Wire Dossier Catalyst Wire Dossier

Hydroxytriptolide

hydroxytriptolide · Shanghai Pharmaceuticals Holding Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hydroxytriptolide, covering 2017-06-05 to 2017-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 1, Phase 2]

See pricing